#USA #New Orleans #Kahn Swick #Geron Corporation #Rytelo

Investigation Launched into Geron Corporation

In a significant development for investors, Kahn Swick & Foti, LLC (KSF), led by former Louisiana Attorney General Charles C. Foti, Jr., has initiated an investigation into Geron Corporation. The inquiry will focus on the conduct of Geron's officers and directors amidst ongoing concerns within the company’s operational and financial landscape.

Throughout 2024, Geron Corporation, known for its innovative cancer treatment, Rytelo, has consistently promoted its revenue potential and expected growth. Rytelo is a telomerase inhibitor aimed at combating malignant cell proliferation, thereby facilitating the generation of healthy cells. However, by the end of the fiscal year, the company disclosed stagnation in Rytelo's sales growth, attributing it to various factors including seasonal fluctuations, increased competition, limited public awareness, and the complexities involved in its treatment protocol.

The situation escalated in February 2025 when Geron announced its financial results, revealing disheartening truths about Rytelo's performance. Investors learned that the anticipated growth had considerably slowed, sparking fears that Geron's optimistic projections were not being met. This prompted a securities class action lawsuit against the company and specific executives, accusing them of failing to disclose critical information during the class period, thus violating federal securities laws.

KSF’s investigation seeks to determine if the executives at Geron breached their fiduciary responsibilities toward shareholders or engaged in unlawful conduct. The law firm urges anyone with relevant information regarding these events to come forward. Long-term holders of Geron shares who are wishing to discuss their legal rights are invited to reach out without any obligation.

Geron Corporation, which trades under the ticker symbol GERN on Nasdaq, is currently at a crossroads, and the outcome of KSF's investigation could have significant ramifications. Stakeholders, including investors, are keenly watching to see how this legal scrutiny may influence future operations and financial stability.

Kahn Swick & Foti, LLC, recognized nationally for its expertise in securities litigation, provides legal representation to a wide range of clients. Their proficiency was recently acknowledged when they ranked among the top ten law firms for total settlement value by SCAS, reflecting their dedication to securing recoveries for entities affected by corporate misconduct.

As Geron navigates this turbulent period, the potential outcomes of KSF's investigation could reshape the company's future strategies and investor relations. For now, the legal community is closely monitoring this case, while investors remain hopeful for clarity amidst the uncertainty surrounding Geron Corporation's operations and leadership.

For those interested in participating in this unfolding narrative, KSF encourages direct communication via their dedicated contact resources, including a toll-free number and an informative website designed to aid affected parties in understanding their circumstances and rights.

This investigation underscores the importance of transparency and accountability within publicly traded companies, exemplifying the critical role that law firms play in maintaining corporate integrity.